Abdel-Magid, A. F. (2012). JAK Kinase Inhibitors as Possible Treatment for Myeloproliferative Disorders and Cancer: Patent Highlight. American Chemical Society.
Citação norma ChicagoAbdel-Magid, Ahmed F. JAK Kinase Inhibitors As Possible Treatment for Myeloproliferative Disorders and Cancer: Patent Highlight. American Chemical Society, 2012.
Citação norma MLAAbdel-Magid, Ahmed F. JAK Kinase Inhibitors As Possible Treatment for Myeloproliferative Disorders and Cancer: Patent Highlight. American Chemical Society, 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.